Earning Preview: Dow Chemical Q2 revenue is expected to increase by 17.31%, and institutional views are cautious

Earnings Agent07-16 13:39

Abstract

Dow Inc. will release second-quarter 2026 results on July 23, 2026 before the market opens (Pre-MKt), with current quarter expectations pointing to roughly 12.00 billion US dollars in revenue and earnings per share of 1.26.

Market Forecast

The latest quarter is expected to show a rebound from a soft first quarter: revenue is projected at 12.00 billion US dollars, up 17.31% year over year, with EBIT forecast at 1.47 billion US dollars, up 17.96% year over year, and adjusted EPS estimated at 1.26, up 8.23% year over year. The previous quarter’s margins set a low base for comparison, with a gross profit margin of 6.53% and a net profit margin of -5.44%; the market will be focused on sequential normalization given the improved volume outlook embedded in the revenue and EBIT forecasts.

Packaging and Specialty Plastics remains the company’s anchor business, and expectations for the quarter center on volume recovery, mix discipline, and operating leverage as shipments normalize from a weak start to the year. Performance Materials and Coatings is positioned as the most promising segment into the print, with last quarter revenue of 2.08 billion US dollars and indications that Q1 sales were lower year over year, creating an easier comparison and potential for sequential improvement as seasonal order patterns strengthen.

Last Quarter Review

Dow Inc. reported first-quarter 2026 revenue of 9.79 billion US dollars (-6.11% year over year), a gross profit margin of 6.53%, a GAAP net loss attributable to shareholders of 0.53 billion US dollars (net profit margin -5.44%), and adjusted EPS of -0.14 (down 800% year over year).

A notable highlight was the continued execution of self-help measures under the company’s Transform to Outperform program, which management emphasized as a key offset to the soft top line and a lever to improve earnings resilience and cash generation. On the business mix, sales were lower year over year across the core segments—Packaging and Specialty Plastics at 4.92 billion US dollars, Industrial Solutions at 2.63 billion US dollars, and Coatings and Performance Monomers at 2.08 billion US dollars—reflecting a broad-based demand softness that the company seeks to counter with price discipline, cost actions, and targeted growth initiatives.

Current Quarter Outlook (with major analytical insights)

Packaging and Specialty Plastics: the core engine to watch

Packaging and Specialty Plastics is the primary earnings driver, and the quarter’s consensus revenue and EBIT improvements implicitly assume better throughput and a more constructive spread environment than the first quarter. At this scale, even modest volume lifts can create meaningful incremental margins as fixed costs are absorbed across higher utilization, especially when product mix remains favorable to higher-value applications. The key read-through for investors will be whether pricing and mix can hold against input variability while volume recovery stays intact, thereby translating the 17.31% revenue growth forecast into a healthier gross margin than last quarter’s 6.53%.

Management’s ongoing operational initiatives are relevant catalysts for this segment. Streamlined operations and procurement efficiencies can add incremental basis-point improvements to segment margins in a rising-volume quarter. With customers in consumer and industrial packaging seeking predictability and performance, the company’s mix of specialty grades provides levers for value selling that can buttress price realization even as order cadence normalizes.

Another lens for the quarter is working-capital intensity in the core plastics chain. If volumes are rising into quarter end, receivables and inventory can briefly expand before converting back to cash, but consistent throughput and disciplined production planning typically help keep cash conversion on track. Investors will parse any color on order backlogs, shipment timing, and price-mix trends to gauge how much of the forecasted EBIT uplift in the quarter is structural versus seasonal, and whether those gains are sustainable into the second half.

Performance Materials and Coatings: the near-term recovery candidate

Performance Materials and Coatings posted 2.08 billion US dollars of revenue last quarter amid a year-over-year decline, setting up an easier comparison and a potentially tangible sequential recovery into the second quarter. This portfolio includes products where seasonal demand helps order flow in the middle of the year, and where price restoration—where justified by differentiated performance—can add incremental tailwinds if input costs stay manageable. The segment’s sensitivity to downstream activity means even moderate improvements in orders can provide earnings lift, amplified by cost measures already in motion.

The qualitative setup this quarter favors tracking price discipline, product availability, and service levels. Where customers require specialty features and consistent performance, maintaining service reliability can reinforce contract stability and support a more elastic volume response as order books replenish. The ability to prioritize higher-contribution SKUs and manage the product mix in favor of higher-margin applications will be a distinguishing factor in how the segment converts incremental revenue into EBIT.

Investors will also monitor how the company balances growth investments with cost containment in this segment. Targeted investments in capabilities and productivity can enhance throughput and margins without materially increasing fixed costs. Against the company-wide effort to simplify operations and improve returns, successful execution in Performance Materials and Coatings can help broaden the earnings base beyond the core packaging vertical and reduce quarter-to-quarter variability in results.

What will likely drive the stock this quarter

The most immediate driver is the scale of margin repair versus the first quarter’s trough-like levels. Consensus implies a robust top-line rebound (12.00 billion US dollars, +17.31% year over year) and a double-digit EBIT uplift (+17.96% year over year to 1.47 billion US dollars). If the company demonstrates that revenue gains translate proportionally into gross margin expansion and a substantially improved net income run-rate from the prior quarter’s -0.53 billion US dollars, the stock reaction should be sensitive to the quality of that conversion. Commentary on pricing sustainability and cost pass-through will be critical in shaping expectations for the second half.

Execution of the Transform to Outperform program will remain in focus. The previous quarter’s narrative underscored cost reductions and organizational simplification, and investors will look for incremental detail on how much of the quarter’s EBIT upside is attributable to structural cost savings versus cyclical or seasonal demand. Any quantified update on realized savings, run-rate benefits, or additional efficiencies can refine the market’s view on normalized mid-cycle earnings, which in turn influences valuation anchors.

Cash generation and capital deployment are the third pillar. With EBIT recovering, the cadence of cash conversion through working-capital management will be closely watched, particularly the interplay between inventory normalization and receivables as volumes rise. Investors will also pay attention to commentary about maintenance versus growth capital needs, the balance of dividend commitments with potential incremental returns of capital, and the prioritization of small, high-return investments that improve asset reliability and product differentiation. A steady cadence of execution updates on strategic projects—such as the company’s progress on energy-efficiency and process-intensity initiatives—can further inform the sustainability of margin and cash improvements.

Analyst Opinions

The balance of recent commentary skews cautious: among views tracked over the current six-month window, bearish opinions account for approximately two-thirds of clear directional calls versus one-third bullish, with neutral takes also present. The majority view emphasizes caution into the print and the following quarters, citing concerns about the durability of pricing and the risk that recent gains may owe more to temporary factors than to a fully re-based earnings power.

BofA Global Research downgraded the shares to underperform and cut its price objective to 35 US dollars, arguing that recent share gains reflect transitory market conditions and that enthusiasm around near-term results could overstate sustainable earnings. BofA further highlighted that even if the quarter benefits from supportive conditions, it has little desire to underwrite what it views as potential “overearning” tied to exogenous dynamics; importantly for the near term, BofA expects pricing pressure to resume following a likely peak around the middle of 2026, which tempers the outlook for margin continuation. This framing dovetails directly with what the market will scrutinize on July 23, 2026: how much of the forecasted EBIT increase to 1.47 billion US dollars is rooted in structural cost and mix improvement versus a combination of temporary spreads and seasonal lift.

BMO Capital reiterated a Sell rating with a 22 US dollar price target, signaling skepticism about the path back to consistent profitability after the first-quarter loss and the depth of self-help required to stabilize returns. In BMO’s view, while the Transform to Outperform program is directionally appropriate and seemingly gaining traction, the speed and magnitude of execution must be sufficient to offset a revenue base that was 9.79 billion US dollars last quarter and still down 6.11% year over year. For the upcoming report, BMO’s bear case rests on the possibility that the quarter shows progress but not enough to convincingly reset investor expectations for a smoother earnings trajectory, especially if the margin commentary is guarded or if management refrains from characterizing improvements as structurally sticky.

Morgan Stanley maintained a Hold stance with a 41 US dollar target, which, although neutral, aligns with the cautious majority in tone by framing the set-up as balanced pending evidence of sustained margin normalization. The implicit message across the cautious and bearish cohort is that the market needs to see a clean bridge from volume recovery to margin durability and cash conversion. If the company can demonstrate that the quarter’s expected revenue lift to 12.00 billion US dollars is accompanied by materially better gross and net margins than the first quarter’s 6.53% and -5.44%, respectively, and provide credible line of sight to sustaining those improvements, the tone of the debate could shift. Until then, the center of gravity of published opinions remains conservative, with a preference for evidence over assumption.

Netting these perspectives, the majority view heading into the release is cautious. The consensus acknowledges that the quarter will likely look better on the surface—revenue up 17.31% year over year, EBIT up 17.96% year over year, and EPS up 8.23% year over year—but insists on validating the quality and persistence of the improvement. The standard for a positive stock reaction is therefore higher-quality beats: signs of gross margin expansion from the first quarter’s 6.53% base, clear articulation of structural savings under the Transform to Outperform program, disciplined price/mix management, and visible cash conversion. Absent those, the majority expects the market to treat a near-term upswing as a bridge rather than a reset, maintaining a wait-and-see posture on the medium-term earnings power and valuation re-rating path.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment